ROCO
6493
Market cap32mUSD
Oct 08, Last price
34.95TWD
1D
0.14%
1Q
-32.79%
Jan 2017
23.59%
IPO
-18.15%
Name
TTBIO Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ttbio Corp. specializes in the development, distribution, and after-sales support of medical devices under its proprietary TTBIO brand, serving both the Taiwanese domestic market and a global clientele. Its product offerings include a range of high-speed and low-speed dental handpieces, alongside essential dental spare components, service rotors, maintenance systems, and advanced electric handpiece solutions. Beyond its core medical device portfolio, Ttbio is also a key supplier of high-precision machined parts and custom components. These are engineered to cater to diverse sectors such as automotive, aerospace, security, and computing hardware, in addition to providing parts for general industrial maintenance and specialized custom projects. Established in 2012, Ttbio Corp. maintains its headquarters in Taichung, Taiwan.
Key people
Jialing Wang
Deputy Manager-Finance Division · since 2014
Xin Zhuang
Head of Finance & Accounting · since 2025
Chairman of the Board · since 2018
Jingliang Chen
Director · since 2018
Yiting Huang
Director · since 2013
Wangzheng Ke
Director
Director
Zhengfang Su
Director · since 2015
General Manager, Director · since 2015
Huiyi Wu
Director · since 2013
Meihong Zhang
Director · since 2013
Fengning Zhang
Director · since 2025
Y.C. Wu
Independent Director · since 2022
Wei'en Wu
Independent Director · since 2022
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||